V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20159932 | 20061529 | 1.65 | 107.4 | Palliative (P) | 2017-07-30 | 2017-08-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101464157 |
| 20159935 | 20061530 | 1.73 | 68.2 | Neo-adjuvant (N) | 2018-11-05 | 2018-11-14 | ECX | N | N | ECX | 101398779 |
| 20159939 | 20061531 | 1.69 | 104 | Adjuvant (A) | 2019-11-19 | 2019-11-30 | ECX | N | N | ECX | 100495787 |
| 20159941 | 20061532 | 1.6 | 75.15 | Palliative (P) | 2016-10-08 | 2016-10-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101850498 |
| 20159947 | 20061533 | 1.88 | 67.8 | Neo-adjuvant (N) | 2018-02-26 | 2018-03-05 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100716286 |
| 20159948 | 20061534 | 1.84 | 66 | Palliative (P) | 2018-12-16 | 2018-12-16 | ECX | N | N | ECX | 101543892 |
| 20159953 | 20061535 | 1.8 | 75.4 | Palliative (P) | 2016-04-10 | 2016-04-13 | ECX | N | Y | ECX | 101025941 |
| 20159954 | 20061536 | 1.71 | 72.4 | Neo-adjuvant (N) | 2019-08-12 | 2019-08-12 | ECX | N | N | ECX | 101457083 |
| 20159955 | 20061537 | 1.83 | 56.8 | Palliative (P) | 2017-11-25 | 2017-12-17 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 101205512 |
| 20159956 | 20061538 | 1.66 | 62.6 | Palliative (P) | 2019-02-17 | 2019-02-18 | ECX | 2 | N | ECX | 101116685 |
| 20159957 | 20061539 | 1.67 | 109 | Adjuvant (A) | 2016-04-07 | 2016-04-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100633547 |
| 20159959 | 20061540 | 1.69 | 60.6 | Palliative (P) | null | 2018-12-29 | ECX | null | N | ECX | 101670886 |
| 20159961 | 20061541 | 1.61 | 72.1 | Adjuvant (A) | 2017-11-03 | 2017-11-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101300581 |
| 20159962 | 20061542 | 1.71 | 85 | Palliative (P) | 2016-05-17 | 2016-07-02 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100303051 |
| 20159964 | 20061543 | 1.58 | 56 | Palliative (P) | 2016-11-10 | 2016-11-10 | ECX | 02 | N | ECX | 101018252 |
| 20159965 | 20061544 | 1.6 | 74.3 | Adjuvant (A) | 2019-09-19 | 2019-09-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101727699 |
| 20159968 | 20061545 | 1.64 | 64 | Palliative (P) | 2019-10-05 | 2019-10-26 | ECX | N | N | ECX | 101706533 |
| 20159969 | 20061546 | 1.72 | 57.6 | Curative (C) | 2017-07-26 | 2017-08-14 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101430841 |
| 20159970 | 20061547 | 1.83 | 63 | Curative (C) | 2020-01-04 | 2020-01-15 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100696167 |
| 20159971 | 20061548 | 1.85 | 90 | Adjuvant (A) | 2017-05-15 | 2017-05-29 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100288327 |
| 20159972 | 20061549 | 1.6 | 72 | Neo-adjuvant (N) | 2016-07-03 | 2016-07-11 | ECX | N | null | ECX | 100843264 |
| 20159975 | 20061550 | 1.7 | 60 | Adjuvant (A) | 2018-04-07 | 2018-04-26 | ECX | null | null | CAPECITABINE + GEMCITABINE | 101318803 |
| 20159978 | 20061551 | 1.6 | 53.7 | Curative (C) | 2018-07-20 | 2018-07-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101267363 |
| 20159982 | 20061552 | 1.8 | 80.1 | Palliative (P) | 2019-10-31 | 2019-11-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101433383 |
| 20159986 | 20061553 | 1.6 | 52.3 | Neo-adjuvant (N) | 2016-10-19 | 2016-10-19 | ECX | 02 | N | ECX | 101141851 |
| 20159987 | 20061554 | 1.6 | 54.5 | Adjuvant (A) | null | 2017-04-20 | CAPECITABINE + GEMCITABINE | 01 | N | CAPECITABINE + GEMCITABINE | 100199177 |
| 20159990 | 20061555 | 1.78 | 83.1 | Adjuvant (A) | 2016-05-26 | 2016-06-19 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100881078 |
| 20159993 | 20061556 | 1.73 | 68.2 | Palliative (P) | 2018-03-13 | 2018-04-12 | Gemcitabine + Capecitabine | 01 | N | CAPECITABINE + GEMCITABINE | 101506108 |
| 20159996 | 20061557 | 1.7 | 62.2 | Palliative (P) | 2019-04-09 | 2019-04-15 | ECX | 02 | N | ECX | 100729850 |
| 20159997 | 20061558 | 1.76 | null | Adjuvant (A) | 2018-10-13 | 2018-10-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100350157 |
| 20159999 | 20061559 | 1.52 | 77.8 | Neo-adjuvant (N) | 2016-11-28 | 2016-12-04 | ECX | N | N | ECX | 100561955 |
| 20160000 | 20061560 | 1.83 | 46.6 | Neo-adjuvant (N) | 2019-06-20 | 2019-06-23 | ECX | 02 | N | ECX | 101752203 |
| 20160002 | 20061561 | 1.56 | 76.4 | Palliative (P) | 2019-10-20 | 2019-10-20 | ECX | N | N | ECX | 100535246 |
| 20160003 | 20061562 | 1.7 | 88.2 | Neo-adjuvant (N) | 2017-11-01 | 2017-11-07 | ECX | N | N | ECX | 101150801 |
| 20160005 | 20061563 | 1.58 | 75.8 | Disease modification (D) | 2019-02-02 | 2019-02-18 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101515788 |
| 20160006 | 20061564 | null | null | Neo-adjuvant (N) | 2017-09-21 | 2017-09-29 | ECX | N | N | ECX | 100789237 |
| 20160009 | 20061565 | 1.8 | 67.4 | Neo-adjuvant (N) | 2017-07-04 | 2017-07-04 | ECX | N | N | ECX | 101313645 |
| 20160010 | 20061566 | 1.61 | 99 | Palliative (P) | 2020-06-02 | 2020-06-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101775737 |
| 20160011 | 20061567 | 1.6 | 82.2 | Adjuvant (A) | 2017-06-12 | 2017-06-24 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101407396 |
| 20160012 | 20061568 | 1.65 | 59.95 | Neo-adjuvant (N) | 2017-04-18 | 2017-04-19 | ECX | N | null | ECX | 100498667 |
| 20160013 | 20061569 | null | null | Neo-adjuvant (N) | 2019-07-12 | 2019-07-26 | ECX | N | N | ECX | 100872475 |
| 20160014 | 20061570 | 1.78 | 78.9 | Palliative (P) | 2017-09-12 | 2017-09-27 | ECX | N | null | ECX | 101748802 |
| 20160015 | 20061571 | 1.75 | 42.6 | Neo-adjuvant (N) | 2017-06-23 | 2017-07-02 | ECX | 02 | N | ECX | 101339224 |
| 20160016 | 20061572 | 1.61 | 49.4 | Neo-adjuvant (N) | 2017-10-17 | 2017-10-18 | ECX | N | null | ECX | 101673430 |
| 20160018 | 20061573 | 1.8 | 73.5 | Palliative (P) | 2016-09-04 | 2016-09-27 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100705871 |
| 20160019 | 20061574 | 1.65 | 75 | Adjuvant (A) | 2019-04-13 | 2019-04-13 | ECX | null | N | ECX | 101011937 |
| 20160020 | 20061575 | 1.79 | 83 | Neo-adjuvant (N) | 2017-07-28 | 2017-08-09 | ECX | 02 | N | ECX | 100562551 |
| 20160022 | 20061576 | 1.71 | 93.8 | Neo-adjuvant (N) | 2019-04-10 | 2019-04-21 | ECX | N | N | ECX | 101516805 |
| 20160023 | 20061577 | 1.52 | 87.9 | Adjuvant (A) | 2018-07-10 | 2018-07-19 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101533016 |
| 20160024 | 20061578 | 1.7 | 76.2 | Adjuvant (A) | 2017-06-01 | 2017-06-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100224389 |